- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The list is piling up.
Drugmakers weighed on broader markets after President Trump targeted high drug prices and Republicans unveiled details of their Obamacare replacement.
The uptick in earnings projections is a 'step in the right direction,' Oppenheimer analyst Brian Nagel said in a note.
The impact of the internet on retailers has the Oracle of Omaha stumped.